After a series of raucous events at industry parties blew up into nasty controversies — highlighting a painfully limited number of women in senior company positions — the leaders of the biotech industry’s chief trade organization says they’ve had enough.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,